Stay updated on Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Mantua, Italy was added to the list of locations and Mantova, Italy was removed.
    Difference
    0.0%
    Check dated 2026-04-09T20:31:20.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added the MeSH term 'Severe myoclonic epilepsy in infancy' to the Additional Relevant MeSH Terms on the study record.
    Difference
    0.1%
    Check dated 2026-04-02T14:54:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed 'Dravet syndrome' from the list of conditions in the study details, affecting how the study's scope and eligibility are described.
    Difference
    0.0%
    Check dated 2026-03-26T05:20:01.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a new revision notice 'Revision: v3.5.0' and removed the previous 'Revision: v3.4.3'.
    Difference
    0.1%
    Check dated 2026-03-19T00:15:13.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T19:58:32.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.